September 23, 2016 — Vision RT announced it will be exhibiting at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting Sept. 25-28 in Boston. New data will be released at this meeting from a trial at the National Cancer Institute (NCI)-accredited Lineberger Cancer Center at the University of North Carolina showing zero radiation-induced abnormalities in blood flow to the heart in all patients where Vision RT’s product was used in left breast radiotherapy. This contrasts with a previous study, using a different technique for similar patients, where 27 percent of patients exhibited heart damage. This data will be presented at an Industry Expert Theater session by Tim Zagar, M.D. At the same session, David Gierga, Ph.D., of Massachusetts General Hospital, will also present on the use of different techniques, including AlignRT, for reproducible breast cancer radiotherapy.
Throughout the meeting there will be live demonstrations on AlignRT for frameless stereotactic radiosurgery (SRS), and for Deep Inspiration Breath Hold (DIBH) breast treatments. Alongside the demonstrations there will be live presentations from clinical experts on the booth, covering breast cancer, stereotactic treatments including frameless SRS, and a variety of other clinical applications.
For more information: www.visionrt.com